Duration of NNM Administration | Gefitinib Administration | N | BrdU-LI FAH, % | BrdU-LI Extrafocal Liver Tissue, % |
---|---|---|---|---|
3 months | 7 | 68.26 ± 6.82 § | 18.07 ± 2.72 | |
3 months | 2 weeks HD | 7 | 60.80 ± 2.80 § | 18.33 ± 2.88 |
3 months | 3 months LD | 7 | 55.49 ± 3.00 § | 12.53 ± 1.29 |